INDBInternet News Database 2.5 Updated 2 min ago · 293 sources Show or hide images Light or dark

Results for “Ozempic Zepbound”

Health
21 sources

Who is covering this

Associated PressCenterPBS NewsHourLeans leftCBS NewsLeans leftNBC NewsLeans leftABC News (US)Leans leftSky NewsLeans rightCNBCCenterUSA TODAYLeans leftThe HillCenterGoogle NewsCenterNDTVCenterQuartzLeans leftGizmodoLeans leftTimes of IndiaCenterNew York PostRightZero HedgeRightWSNS-TVNot ratedThe Seattle TimesNot ratedKING-TVNot ratedKHOUNot ratedWGRZNot rated
Truth score 906
Left 44%44%Centre 38%38%Right 19%19%
Associated PressCenter

FDA adds rare vision-loss warning to popular GLP-1 drugs

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands. The Food and Drug Administration is adding a new warning about possible...

Lean: Center VideoFactuality: Very highCountry: United StatesFunding: NonprofitOwner: AP (Cooperative)
  • ABC News (US) FDA orders new warning on Ozempic, Wegovy, other GLP-1 drugs over rare eye condition

    The FDA says popular diabetes and weight loss drugs may increase the risk of a rare condition that can cause permanent vision loss. ---- Subscribe to ABC News on YouTube: https://abcnews.visitlink.me/59aJ1G ABC News...

    Lean: Leans left VideoFactuality: HighCountry: United StatesFunding: CorporateOwner: Walt Disney Company
  • PBS NewsHour FDA issues vision loss warning for GLP-1 drugs

    The Food and Drug Administration issued a new warning on Monday about the risk of vision loss related to popular GLP-1 weight loss and diabetes drugs. Health officials say drugs like Eli Lilly’s Zepbound and Ozempic...

    Lean: Leans left VideoFactuality: Very highCountry: United StatesFunding: Public broadcasterOwner: PBS (Nonprofit)
  • CBS News What to know about new GLP-1 warning on possible vision loss

    Dr. Jon LaPook joins "CBS Mornings" to break down the facts on a new warning about GLP-1 medications causing possible vision loss.

    Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Paramount Global
  • NBC News FDA Orders Warning Label on GLP-1s for Risk of Eye Condition

    The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss.

    Lean: Leans left VideoFactuality: HighCountry: United StatesFunding: CorporateOwner: Comcast
+ 24 · Full coverage
Coverage breakdown
Funding
Corporate62%
Not recorded24%
Nonprofit5%
Public broadcaster5%
Private5%
Countries
United States86%
India10%
United Kingdom5%
Media ownership
Comcast14%
G/O Media14%
WSNS-TV7%
Independent7%
Google News7%
Avg reliability74
Low-credibility share6%
Fact / opinion29/0
State media0%
More analysis
Truth score: 90 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 21 Reliability: 74 Bias severity: 40 Risk: 6Sentiment: -97Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Culture
1 source

Who is covering this

QuartzLeans left
Truth score 40
Left 100%100%
QuartzLeans left

How Ozempic and Zepbound are reshaping 10 industries

Industries affected by GLP-1 drugs like Ozempic and Zepbound range from drugmakers and pen manufacturers to diet programs, snack makers and insurers, with mixed and uncertain effects

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
G/O Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
Culture
1 source

Who is covering this

QuartzLeans left
Truth score 40
Left 100%100%
QuartzLeans left

11 GLP-1 side effects to know before taking Ozempic, Wegovy, or Zepbound

From nausea to bone loss, GLP-1 drugs such as Ozempic, Wegovy, and Zepbound can cause side effects. Here are 11 to know, plus tips to manage them.

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
G/O Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
1 source

Who is covering this

India TodayCenter
Truth score 40
Centre 100%100%
India TodayCenter

Ozempic teeth: Can weight-loss injections damage your teeth and gums?

Ozempic teeth Can weightloss injections damage your teeth and gums

Lean: Center Fact-focusedFactuality: HighCountry: IndiaFunding: CorporateOwner: Living Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Living Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 6 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
1 source

Who is covering this

BuzzFeedLeans left
Truth score 34
No rated outlets yet
BuzzFeedLeans left

“Ozempic Vagina” Is The Latest GLP-1 “Side Effect” To Take The Internet By Storm, So Here’s What It Actually Means

While many are aware of terms like "Ozempic face" and "Ozempic butt," people are discovering another "side effect" of GLP-1 medications.

Lean: Leans left Fact-focusedCountry: United StatesFunding: CorporateOwner: BuzzFeed Inc.
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
BuzzFeed Inc.100%
Avg reliability-
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 34 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: Not rated Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Politics
1 source

Who is covering this

Drudge Report FeedLeans right
Truth score 34
Right 100%100%
Drudge Report FeedLeans right

FDA new OZEMPIC warning: Blindness...

FDA new OZEMPIC warning: Blindness... (Second column, 13th story, link )

Lean: Leans right Fact-focusedCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability-
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 34 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: Not rated Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 8 Amplification: 0

How we score

Analyze: Compare coverage
Like
Entertainment
1 source

Who is covering this

Times of IndiaCenter
Truth score 38
Centre 100%100%
Times of IndiaCenter

Amrita Arora reacts to Ozempic and Mounjaro speculation after her 14 kg weight loss

Amrita Arora Ladak has undergone a significant transformation, shedding 14 kg and embracing a journey of personal redemption. This endeavor has been both emotionally and physically taxing, yet fulfilling. Despite rumors surrounding her...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Retatrutide Tops Ozempic for Weight Loss, A1c in T2D

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

Can a Chinese plant extract really combat Ozempic face? Tiktok is convinced - now experts reveal the truth about viral cream

It's an unwelcome side effect of weight loss jabs used by millions of Britons. 'Ozempic face' can leave users with gaunt features such as hollow cheeks, sagging skin and sunken eyes.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
1 source

Who is covering this

ABC News (Australia)Center
Truth score 45
Centre 100%100%
ABC News (Australia)Center

Study links heart issues to starting and stopping Ozempic-like drugs

A large study suggests people with type 2 diabetes who start and then stop GLP-1 drugs may have poorer health outcomes, but more research is needed.

Lean: Center Fact-focusedFactuality: Very highCountry: AustraliaFunding: Public broadcasterOwner: Australian Government
Full coverage
Coverage breakdown
Funding
Public broadcaster100%
Countries
Australia100%
Media ownership
Australian Government100%
Avg reliability86
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 45 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 86 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
1 source

Who is covering this

The Daily BeastLeft
Truth score 38
Left 100%100%
The Daily BeastLeft

GLP-1 Jabs Linked to Scary Side Effect That’s Worse Than ‘Ozempic Face’

Kemal Yildirim / Getty Images First there were fears of “ Ozempic butt ,” then of “ Ozempic face .” But a newly discovered potential risk of popular weight loss drugs affects more than just the surface. Glucagon-like peptide-1 receptor...

Lean: Left Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: IAC
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
IAC100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like